Tokyo, Sept. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063067) titled 'Safety, Adverse Events, and Pharmacokinetics/Therapeutic Drug Monitoring of Sirolimus in Infants Under One Year of Age: A Scoping Review' on Sept. 28.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Nagoya City University
Condition:
Condition - Diseases requiring sirolimus administration in infants under 1 year of age (e.g., vascular malformations, tuberous sclerosis, lymphatic anomalies)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To conduct a scoping review of existing literature to comprehensively evaluate the safety, adverse events, tole...